XML 57 R47.htm IDEA: XBRL DOCUMENT v3.25.3
Discontinued Operations - Reconciliation of Discontinued Operations (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Costs and expenses:        
Net income (loss) from discontinued operations, net of tax $ 8,986 $ 36,848 $ 342,444 $ 248,504
Discontinued Operations Disposed of by Sale        
Discontinued Operations        
Net revenue 10,663   65,891  
Costs and expenses:        
Cost of goods sold 287   26,184  
Research and development 564   726  
Selling, general and administrative 326   9,809  
Total costs and expenses 1,177   36,719  
Income from operations 9,486   29,172  
Interest expense     (3,484)  
Loss on debt extinguishment     (10,286)  
Other income (expense), net (78)   (11,638)  
Gain on Sale Transactions, net (422)   338,680  
Net income (loss) from discontinued operations before income taxes 8,986   342,444  
Net income (loss) from discontinued operations, net of tax 8,986   342,444  
Discontinued Operations Disposed of by Sale | UDENYCA        
Discontinued Operations        
Net revenue $ 10,663   65,315  
Costs and expenses:        
Loss on debt extinguishment     10,300  
Discontinued Operations Disposed of by Sale | YUSIMRY Sale        
Discontinued Operations        
Net revenue     43  
Discontinued Operations Disposed of by Sale | CIMERLI ophthalmology franchise        
Discontinued Operations        
Net revenue     $ 533  
Assets Held For Sale        
Discontinued Operations        
Net revenue   64,722   194,160
Costs and expenses:        
Cost of goods sold   18,012   77,718
Research and development   (376)   1,027
Selling, general and administrative   6,617   30,567
Total costs and expenses   24,253   109,312
Income from operations   40,469   84,848
Interest expense   (2,535)   (12,990)
Gain on Sale Transactions, net   (1,086)   176,646
Net income (loss) from discontinued operations before income taxes   36,848   248,504
Net income (loss) from discontinued operations, net of tax   36,848   248,504
Assets Held For Sale | UDENYCA        
Discontinued Operations        
Net revenue   66,089   159,673
Costs and expenses:        
Gain on Sale Transactions, net       176,600
Assets Held For Sale | YUSIMRY Sale        
Discontinued Operations        
Net revenue   (152)   7,508
Assets Held For Sale | CIMERLI ophthalmology franchise        
Discontinued Operations        
Net revenue   $ (1,215)   $ 26,979